Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with Sjögren syndrome

Osama M A Ibrahim, Murat Dogru, Shinichi Kawashima, Tais H. Wakamatsu, Kazuo Tsubota, Hiroshi Fujishima

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: To evaluate tear meniscus changes in patients with Sjögren syndrome (SS) receiving oral pilocarpine with Visante optical coherence tomography (OCT). Methods: Eight patients with primary SS were recruited in this prospective interventional case series study. Patients received pilocarpine tablets twice a day for 3 months. Visual analog scale assessment for dry eye and dry mouth symptoms was carried out. Patients underwent OCT and slit-lamp microscopy graticule scale tear meniscus height (TMH) measurements, strip meniscometry testing, tear film breakup time measurement, fluorescein and Rose Bengal staining, and the Schirmer 1 test. The data were analyzed 1 week, 1 month, and 3 months after treatment. Mann-Whitney test was performed. Results: Visual analog scale assessment showed a significant time-wise improvement (P < 0.05). OCT and graticule scale TMH measurements significantly improved after 1 week (P < 0.05), 1 month, and 3 months of treatment (P < 0.001). Strip meniscometry, mean tear film stability, and fluorescein and Rose Bengal scores remained improved 3 months after treatment (P < 0.001), whereas Schirmer 1 test values tended to improve without statistical significance. Conclusions: Visante OCT was effective in monitoring tear meniscus changes during the course of treatment noninvasively and quickly. Oral pilocarpine seemed to be effective in improving TMH, and the signs and symptoms of dryness in patients with SS.

Original languageEnglish
Pages (from-to)653-657
Number of pages5
JournalCornea
Volume32
Issue number5
DOIs
Publication statusPublished - 2013 May

Fingerprint

Optical Coherence Tomography
Tears
Cholinergic Agents
Pilocarpine
Rose Bengal
Fluorescein
Visual Analog Scale
Therapeutics
Tablets
Signs and Symptoms
Mouth
Meniscus
Staining and Labeling

Keywords

  • cholinergic treatment
  • optical coherence tomography
  • Sjögren syndrome
  • tear meniscus height

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with Sjögren syndrome. / Ibrahim, Osama M A; Dogru, Murat; Kawashima, Shinichi; Wakamatsu, Tais H.; Tsubota, Kazuo; Fujishima, Hiroshi.

In: Cornea, Vol. 32, No. 5, 05.2013, p. 653-657.

Research output: Contribution to journalArticle

Ibrahim, Osama M A ; Dogru, Murat ; Kawashima, Shinichi ; Wakamatsu, Tais H. ; Tsubota, Kazuo ; Fujishima, Hiroshi. / Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with Sjögren syndrome. In: Cornea. 2013 ; Vol. 32, No. 5. pp. 653-657.
@article{128fd87422d2401bb57aad4033521912,
title = "Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with Sj{\"o}gren syndrome",
abstract = "Purpose: To evaluate tear meniscus changes in patients with Sj{\"o}gren syndrome (SS) receiving oral pilocarpine with Visante optical coherence tomography (OCT). Methods: Eight patients with primary SS were recruited in this prospective interventional case series study. Patients received pilocarpine tablets twice a day for 3 months. Visual analog scale assessment for dry eye and dry mouth symptoms was carried out. Patients underwent OCT and slit-lamp microscopy graticule scale tear meniscus height (TMH) measurements, strip meniscometry testing, tear film breakup time measurement, fluorescein and Rose Bengal staining, and the Schirmer 1 test. The data were analyzed 1 week, 1 month, and 3 months after treatment. Mann-Whitney test was performed. Results: Visual analog scale assessment showed a significant time-wise improvement (P < 0.05). OCT and graticule scale TMH measurements significantly improved after 1 week (P < 0.05), 1 month, and 3 months of treatment (P < 0.001). Strip meniscometry, mean tear film stability, and fluorescein and Rose Bengal scores remained improved 3 months after treatment (P < 0.001), whereas Schirmer 1 test values tended to improve without statistical significance. Conclusions: Visante OCT was effective in monitoring tear meniscus changes during the course of treatment noninvasively and quickly. Oral pilocarpine seemed to be effective in improving TMH, and the signs and symptoms of dryness in patients with SS.",
keywords = "cholinergic treatment, optical coherence tomography, Sj{\"o}gren syndrome, tear meniscus height",
author = "Ibrahim, {Osama M A} and Murat Dogru and Shinichi Kawashima and Wakamatsu, {Tais H.} and Kazuo Tsubota and Hiroshi Fujishima",
year = "2013",
month = "5",
doi = "10.1097/ICO.0b013e318261eb4a",
language = "English",
volume = "32",
pages = "653--657",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with Sjögren syndrome

AU - Ibrahim, Osama M A

AU - Dogru, Murat

AU - Kawashima, Shinichi

AU - Wakamatsu, Tais H.

AU - Tsubota, Kazuo

AU - Fujishima, Hiroshi

PY - 2013/5

Y1 - 2013/5

N2 - Purpose: To evaluate tear meniscus changes in patients with Sjögren syndrome (SS) receiving oral pilocarpine with Visante optical coherence tomography (OCT). Methods: Eight patients with primary SS were recruited in this prospective interventional case series study. Patients received pilocarpine tablets twice a day for 3 months. Visual analog scale assessment for dry eye and dry mouth symptoms was carried out. Patients underwent OCT and slit-lamp microscopy graticule scale tear meniscus height (TMH) measurements, strip meniscometry testing, tear film breakup time measurement, fluorescein and Rose Bengal staining, and the Schirmer 1 test. The data were analyzed 1 week, 1 month, and 3 months after treatment. Mann-Whitney test was performed. Results: Visual analog scale assessment showed a significant time-wise improvement (P < 0.05). OCT and graticule scale TMH measurements significantly improved after 1 week (P < 0.05), 1 month, and 3 months of treatment (P < 0.001). Strip meniscometry, mean tear film stability, and fluorescein and Rose Bengal scores remained improved 3 months after treatment (P < 0.001), whereas Schirmer 1 test values tended to improve without statistical significance. Conclusions: Visante OCT was effective in monitoring tear meniscus changes during the course of treatment noninvasively and quickly. Oral pilocarpine seemed to be effective in improving TMH, and the signs and symptoms of dryness in patients with SS.

AB - Purpose: To evaluate tear meniscus changes in patients with Sjögren syndrome (SS) receiving oral pilocarpine with Visante optical coherence tomography (OCT). Methods: Eight patients with primary SS were recruited in this prospective interventional case series study. Patients received pilocarpine tablets twice a day for 3 months. Visual analog scale assessment for dry eye and dry mouth symptoms was carried out. Patients underwent OCT and slit-lamp microscopy graticule scale tear meniscus height (TMH) measurements, strip meniscometry testing, tear film breakup time measurement, fluorescein and Rose Bengal staining, and the Schirmer 1 test. The data were analyzed 1 week, 1 month, and 3 months after treatment. Mann-Whitney test was performed. Results: Visual analog scale assessment showed a significant time-wise improvement (P < 0.05). OCT and graticule scale TMH measurements significantly improved after 1 week (P < 0.05), 1 month, and 3 months of treatment (P < 0.001). Strip meniscometry, mean tear film stability, and fluorescein and Rose Bengal scores remained improved 3 months after treatment (P < 0.001), whereas Schirmer 1 test values tended to improve without statistical significance. Conclusions: Visante OCT was effective in monitoring tear meniscus changes during the course of treatment noninvasively and quickly. Oral pilocarpine seemed to be effective in improving TMH, and the signs and symptoms of dryness in patients with SS.

KW - cholinergic treatment

KW - optical coherence tomography

KW - Sjögren syndrome

KW - tear meniscus height

UR - http://www.scopus.com/inward/record.url?scp=84876291298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876291298&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e318261eb4a

DO - 10.1097/ICO.0b013e318261eb4a

M3 - Article

VL - 32

SP - 653

EP - 657

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 5

ER -